Article
Successful Regulatory T Cell-Based Therapy Relies on Inhibition of T Cell Effector…
Journal of Immunology Research · 2019 · S. Landman, author V. L. de Oliveira, author M. Peppelman, author E. Fasse, author E. van Rijssen, author S. C. Bauland, author P. van Erp, author I. Joosten, author H. J. P. M. Koenen, author Kurt Blaser, Academic Editor
Key facts
| Title | Successful Regulatory T Cell-Based Therapy Relies on Inhibition of T Cell Effector Function and Enrichment of FOXP3+ Cells in a Humanized Mouse Model of Skin Inflammation |
|---|---|
| First author | S. Landman, author V. L. de Oliveira, author M. Peppelman, author E. Fasse, author E. van Rijssen, author S. C. Bauland, author P. van Erp, author I. Joosten, author H. J. P. M. Koenen, author Kurt Blaser, Academic Editor |
| Journal | Journal of Immunology Research |
| Published | Aug 16, 2019 |
| DOI | 10.1155/2020/7680131 |
| Devices mentioned | K032692, K073490, K130373, K162897, K951965 |
| Product codes mentioned | CFN, DEH, JZG, OYE, GIA, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1